{
  "medication_classes": {
    "LABA": {
      "name": "Long-Acting Beta-2 Agonists",
      "mechanism": "Bronchodilation via beta-2 receptor stimulation, relaxes smooth muscle",
      "duration": "12-24 hours",
      "medications": [
        {
          "name": "Salmeterol",
          "brand_names": ["Serevent"],
          "dose": "50 mcg",
          "frequency": "Twice daily",
          "device": "Dry powder inhaler (DPI)",
          "onset": "Slow (120 minutes)",
          "duration": "12 hours",
          "special_notes": "Most studied standalone LABA, slow onset limits use as rescue"
        },
        {
          "name": "Formoterol",
          "brand_names": ["Foradil", "Perforomist"],
          "dose": "20 mcg (DPI) or 20 mcg/2 mL (nebulizer)",
          "frequency": "Twice daily",
          "device": "DPI or nebulizer solution",
          "onset": "Rapid (3 minutes)",
          "duration": "12 hours",
          "special_notes": "Rapid onset, available in nebulized form"
        },
        {
          "name": "Arformoterol",
          "brand_names": ["Brovana"],
          "dose": "15 mcg/2 mL",
          "frequency": "Twice daily",
          "device": "Nebulizer solution only",
          "onset": "Rapid",
          "duration": "12 hours",
          "special_notes": "R-enantiomer of formoterol, nebulized only"
        },
        {
          "name": "Indacaterol",
          "brand_names": ["Arcapta"],
          "dose": "75-150 mcg",
          "frequency": "Once daily",
          "device": "DPI",
          "onset": "Rapid",
          "duration": "24 hours",
          "special_notes": "Once-daily dosing, withdrawn from US/Canada market but available elsewhere"
        },
        {
          "name": "Olodaterol",
          "brand_names": ["Striverdi"],
          "dose": "2.5 mcg per actuation (2 inhalations)",
          "frequency": "Once daily",
          "device": "Soft mist inhaler (SMI)",
          "onset": "Rapid",
          "duration": "24 hours",
          "special_notes": "Soft mist delivery, helpful for poor inspiratory flow"
        },
        {
          "name": "Vilanterol",
          "brand_names": ["Available only in combinations"],
          "dose": "25 mcg",
          "frequency": "Once daily",
          "device": "DPI",
          "onset": "Intermediate (15 minutes)",
          "duration": "24 hours",
          "special_notes": "Available only in combination with umeclidinium or fluticasone"
        }
      ]
    },
    "LAMA": {
      "name": "Long-Acting Muscarinic Antagonists",
      "mechanism": "Bronchodilation via cholinergic blockade, reduces vagal tone",
      "duration": "12-24 hours",
      "medications": [
        {
          "name": "Tiotropium",
          "brand_names": ["Spiriva HandiHaler", "Spiriva Respimat"],
          "dose": "18 mcg (DPI) or 2.5 mcg per actuation, 2 inhalations (SMI)",
          "frequency": "Once daily",
          "device": "DPI or SMI",
          "onset": "30 minutes",
          "duration": "24 hours",
          "special_notes": "Most extensively studied LAMA, reduces hyperinflation, excreted renally"
        },
        {
          "name": "Aclidinium",
          "brand_names": ["Tudorza"],
          "dose": "400 mcg",
          "frequency": "Twice daily",
          "device": "DPI",
          "onset": "Minutes",
          "duration": "12 hours",
          "special_notes": "Very low bioavailability (<5%), may reduce systemic side effects"
        },
        {
          "name": "Umeclidinium",
          "brand_names": ["Incruse Ellipta"],
          "dose": "62.5 mcg",
          "frequency": "Once daily",
          "device": "DPI",
          "onset": "Minutes, peak at 3 hours",
          "duration": "24 hours",
          "special_notes": "Once-daily dosing, sustained bronchodilation"
        },
        {
          "name": "Glycopyrrolate (Glycopyrronium)",
          "brand_names": ["Seebri", "Lonhala"],
          "dose": "50 mcg (DPI) or 25 mcg twice daily",
          "frequency": "Once or twice daily depending on formulation",
          "device": "DPI or nebulizer",
          "onset": "Minutes",
          "duration": "12-24 hours",
          "special_notes": "Similar efficacy to tiotropium, excreted renally"
        },
        {
          "name": "Revefenacin",
          "brand_names": ["Yupelri"],
          "dose": "175 mcg/3 mL",
          "frequency": "Once daily",
          "device": "Standard jet nebulizer only",
          "onset": "Minutes",
          "duration": "24 hours",
          "special_notes": "Nebulized LAMA, reserved for patients unable to use inhalers, avoid in hepatic impairment"
        }
      ]
    },
    "LAMA_LABA_combinations": {
      "name": "LAMA-LABA Fixed-Dose Combinations",
      "rationale": "Improved adherence, complementary mechanisms, reduced pill burden",
      "medications": [
        {
          "name": "Tiotropium-Olodaterol",
          "brand_names": ["Stiolto Respimat"],
          "components": "Tiotropium 2.5 mcg + Olodaterol 2.5 mcg per actuation",
          "dose": "2 inhalations",
          "frequency": "Once daily",
          "device": "SMI",
          "special_notes": "Soft mist delivery system"
        },
        {
          "name": "Umeclidinium-Vilanterol",
          "brand_names": ["Anoro Ellipta"],
          "components": "Umeclidinium 62.5 mcg + Vilanterol 25 mcg",
          "dose": "1 inhalation",
          "frequency": "Once daily",
          "device": "DPI",
          "special_notes": "Simple once-daily dosing"
        },
        {
          "name": "Glycopyrronium-Indacaterol",
          "brand_names": ["Ultibro", "Utibron"],
          "components": "Glycopyrronium 50 mcg + Indacaterol 110 mcg",
          "dose": "1 capsule",
          "frequency": "Once daily",
          "device": "DPI",
          "special_notes": "Available in some regions, not currently marketed in US"
        },
        {
          "name": "Glycopyrrolate-Formoterol",
          "brand_names": ["Bevespi Aerosphere"],
          "components": "Glycopyrrolate 9 mcg + Formoterol 4.8 mcg per actuation",
          "dose": "2 inhalations",
          "frequency": "Twice daily",
          "device": "Metered dose inhaler (MDI)",
          "special_notes": "MDI formulation, twice-daily dosing"
        },
        {
          "name": "Aclidinium-Formoterol",
          "brand_names": ["Duaklir"],
          "components": "Aclidinium 400 mcg + Formoterol 12 mcg",
          "dose": "1 inhalation",
          "frequency": "Twice daily",
          "device": "DPI",
          "special_notes": "Twice-daily dosing"
        }
      ]
    },
    "LABA_ICS_combinations": {
      "name": "LABA-ICS Fixed-Dose Combinations",
      "indication": "Alternative for Group E patients who cannot use LAMA",
      "medications": [
        {
          "name": "Salmeterol-Fluticasone",
          "brand_names": ["Advair Diskus", "Advair HFA"],
          "components": "Salmeterol 50 mcg + Fluticasone 100, 250, or 500 mcg",
          "dose": "1 inhalation",
          "frequency": "Twice daily",
          "device": "DPI or MDI",
          "special_notes": "Most studied LABA-ICS combination"
        },
        {
          "name": "Formoterol-Budesonide",
          "brand_names": ["Symbicort"],
          "components": "Formoterol 4.5 mcg + Budesonide 80 or 160 mcg",
          "dose": "2 inhalations",
          "frequency": "Twice daily",
          "device": "MDI",
          "special_notes": "Rapid-onset LABA component"
        },
        {
          "name": "Vilanterol-Fluticasone furoate",
          "brand_names": ["Breo Ellipta"],
          "components": "Vilanterol 25 mcg + Fluticasone furoate 100 or 200 mcg",
          "dose": "1 inhalation",
          "frequency": "Once daily",
          "device": "DPI",
          "special_notes": "Once-daily dosing"
        },
        {
          "name": "Formoterol-Mometasone",
          "brand_names": ["Dulera"],
          "components": "Formoterol 5 mcg + Mometasone 100 or 200 mcg",
          "dose": "2 inhalations",
          "frequency": "Twice daily",
          "device": "MDI",
          "special_notes": "Available for COPD in some regions"
        }
      ]
    },
    "triple_therapy": {
      "name": "LAMA-LABA-ICS Triple Therapy",
      "indication": "Group E with high eosinophils (≥300 cells/μL) or frequent exacerbations",
      "approaches": [
        "Single-inhaler triple therapy (preferred for adherence)",
        "LAMA + LABA-ICS combination (two inhalers)",
        "Three separate inhalers (not preferred)"
      ],
      "medications": [
        {
          "name": "Umeclidinium-Vilanterol-Fluticasone furoate",
          "brand_names": ["Trelegy Ellipta"],
          "components": "Umeclidinium 62.5 mcg + Vilanterol 25 mcg + Fluticasone furoate 100 mcg",
          "dose": "1 inhalation",
          "frequency": "Once daily",
          "device": "DPI",
          "special_notes": "Single-inhaler triple therapy, once-daily"
        },
        {
          "name": "Glycopyrronium-Formoterol-Beclometasone",
          "brand_names": ["Trimbow"],
          "components": "Glycopyrronium 10 mcg + Formoterol 5 mcg + Beclometasone 87 mcg",
          "dose": "2 inhalations",
          "frequency": "Twice daily",
          "device": "MDI",
          "special_notes": "Extrafine particle formulation"
        }
      ]
    },
    "SABA": {
      "name": "Short-Acting Beta-2 Agonists",
      "indication": "Rescue therapy for all patients",
      "medications": [
        {
          "name": "Albuterol (Salbutamol)",
          "brand_names": ["ProAir", "Ventolin", "Proventil"],
          "dose": "90 mcg per actuation",
          "frequency": "2 puffs as needed, up to every 4-6 hours",
          "device": "MDI or nebulizer solution (2.5 mg/3 mL)",
          "onset": "5 minutes",
          "duration": "4-6 hours",
          "special_notes": "Most commonly used rescue bronchodilator"
        },
        {
          "name": "Levalbuterol",
          "brand_names": ["Xopenex"],
          "dose": "45 mcg per actuation",
          "frequency": "2 puffs as needed, up to every 4-6 hours",
          "device": "MDI or nebulizer solution",
          "onset": "5 minutes",
          "duration": "4-6 hours",
          "special_notes": "R-enantiomer of albuterol, may have fewer cardiovascular effects"
        }
      ]
    },
    "SAMA": {
      "name": "Short-Acting Muscarinic Antagonists",
      "indication": "Rescue therapy (combination with SABA for patients not on LAMA)",
      "medications": [
        {
          "name": "Ipratropium",
          "brand_names": ["Atrovent"],
          "dose": "17 mcg per actuation",
          "frequency": "2 inhalations 4 times daily as needed",
          "device": "MDI or nebulizer solution (0.5 mg/2.5 mL)",
          "onset": "15 minutes",
          "duration": "4-6 hours",
          "special_notes": "Not recommended with LAMA therapy due to cumulative anticholinergic effects"
        }
      ]
    },
    "SABA_SAMA_combinations": {
      "name": "SABA-SAMA Combinations",
      "indication": "Rescue therapy for patients not on LAMA",
      "medications": [
        {
          "name": "Ipratropium-Albuterol",
          "brand_names": ["Combivent Respimat", "DuoNeb"],
          "components": "Ipratropium 20 mcg + Albuterol 100 mcg per actuation",
          "dose": "1 inhalation",
          "frequency": "Every 4-6 hours as needed",
          "device": "SMI or nebulizer solution (0.5 mg ipratropium + 2.5 mg albuterol/3 mL)",
          "special_notes": "Synergistic bronchodilation, preferred rescue for patients not on LAMA"
        }
      ]
    }
  },
  "device_types": {
    "MDI": {
      "name": "Metered Dose Inhaler",
      "technique_key_points": [
        "Shake inhaler before use",
        "Exhale completely",
        "Seal lips around mouthpiece",
        "Press canister while inhaling slowly and deeply",
        "Hold breath for 10 seconds",
        "Wait 30-60 seconds between puffs"
      ],
      "advantages": ["Portable", "Quick", "Consistent dose"],
      "disadvantages": ["Requires coordination", "Propellant spray can trigger cough"],
      "spacer_recommended": true
    },
    "DPI": {
      "name": "Dry Powder Inhaler",
      "technique_key_points": [
        "Do not shake",
        "Exhale completely away from device",
        "Seal lips around mouthpiece",
        "Inhale rapidly and deeply (breath-actuated)",
        "Hold breath for 10 seconds"
      ],
      "advantages": ["Breath-actuated", "No propellant", "Less coordination needed"],
      "disadvantages": ["Requires adequate inspiratory flow", "Humidity sensitive"],
      "spacer_recommended": false
    },
    "SMI": {
      "name": "Soft Mist Inhaler",
      "technique_key_points": [
        "Load dose by turning base",
        "Exhale completely",
        "Seal lips around mouthpiece",
        "Press release button while inhaling slowly",
        "Hold breath for 10 seconds"
      ],
      "advantages": ["Slow-moving mist", "Good for poor inspiratory flow", "High lung deposition"],
      "disadvantages": ["More steps to use", "More expensive"],
      "spacer_recommended": false
    },
    "Nebulizer": {
      "name": "Nebulizer",
      "technique_key_points": [
        "Add medication to nebulizer cup",
        "Breathe normally through mouthpiece or mask",
        "Continue until mist stops (8-15 minutes)"
      ],
      "advantages": ["No coordination needed", "High dose delivery", "Good for severe disease"],
      "disadvantages": ["Time-consuming", "Requires equipment", "Not portable"],
      "spacer_recommended": false
    }
  },
  "side_effects_management": {
    "LABA_side_effects": {
      "tremor": "Reduce dose or switch to LAMA",
      "tachycardia": "Monitor heart rate, consider dose reduction or LAMA alternative",
      "palpitations": "ECG if persistent, consider switching to LAMA",
      "hypokalemia": "Monitor potassium, especially with high doses or diuretic use"
    },
    "LAMA_side_effects": {
      "dry_mouth": "Most common, rinse mouth after use, sips of water, sugar-free candy",
      "urinary_retention": "Monitor in patients with BPH, consider LABA alternative",
      "constipation": "Increase fiber and fluids, consider stool softener",
      "blurred_vision": "Ensure mist not directed toward eyes, consider alternative if persistent"
    },
    "ICS_side_effects": {
      "oral_candidiasis": "Rinse mouth and spit after each use, treat with antifungal if occurs",
      "dysphonia": "Rinse mouth after use, voice rest, reduce dose if severe",
      "pneumonia_risk": "Increased risk especially with high doses; use lowest effective dose",
      "bruising": "Common with long-term use, generally not serious",
      "cataracts": "Screen annually with long-term use",
      "osteoporosis": "Bone density screening, calcium/vitamin D supplementation"
    }
  },
  "drug_interactions": {
    "LABA": [
      "Beta-blockers: may reduce effectiveness or cause bronchospasm",
      "MAO inhibitors, tricyclic antidepressants: may potentiate cardiovascular effects",
      "Diuretics: may worsen hypokalemia",
      "QT-prolonging drugs: additive effect on QT interval"
    ],
    "LAMA": [
      "Other anticholinergics: additive anticholinergic effects",
      "Drugs that cause urinary retention: increased risk"
    ],
    "ICS": [
      "Strong CYP3A4 inhibitors (ritonavir, ketoconazole): increased systemic exposure",
      "Live vaccines: theoretical risk with high-dose ICS"
    ]
  },
  "special_populations": {
    "renal_impairment": {
      "LAMA": "Tiotropium and glycopyrrolate excreted renally - monitor for anticholinergic effects; aclidinium safer (low bioavailability)",
      "LABA": "Generally safe, no dose adjustment needed"
    },
    "hepatic_impairment": {
      "revefenacin": "Avoid use in hepatic impairment",
      "other_medications": "Generally safe with dose adjustments as needed"
    },
    "cardiovascular_disease": {
      "monitoring": "Monitor for arrhythmias, tachycardia with LABA use",
      "safety": "Both LABA and LAMA generally safe; individualize therapy"
    },
    "narrow_angle_glaucoma": {
      "LAMA": "Use with caution, ensure mist not directed toward eyes",
      "LABA_ICS": "Safe alternatives"
    },
    "BPH": {
      "LAMA": "Increased urinary retention risk; monitor closely or use LABA",
      "aclidinium": "May be safer due to low bioavailability"
    }
  }
}
